The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

NCT00936871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Lersivirine
DRUG: Placebo
DRUG: Lersivirine (if necessary)
DRUG: Lersivirine
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Pfizer